Atorvastatin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.

Category

HMG-COA Reductase Inhibitor